Covid-19 roundup: EU opts in­to 80M more Mod­er­na vac­cine dos­es; Boehringer In­gel­heim takes its an­ti­bod­ies in­to the clin­ic

On the heels of its unan­i­mous 20-0 ad­comm vote in the US, Mod­er­na has an­nounced a new deal for its Covid-19 vac­cine in Eu­rope …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.